MRK Trading Analysis - 11/13/2026 11:41 AM โ€” TRU-SENTIMENT

MRK (Merck & Co. Inc.) at $146.51. True Sentiment Bullish, delta 40-60 call 78% / put 22%, call $719,082 vs put $202,725. RSI 53.3.

TRU-SENTIMENT ยท DeltaNeutral

MRK Trading Analysis - 11/13/2026 11:41 AM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

MRK (Merck & Co. Inc.) at $146.51. True Sentiment Bullish, delta 40-60 call 78% / put 22%, call $719,082 vs put $202,725. RSI 53.3.

Symbol
MRK
Price
$146.51
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-13 11:41:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From MRK_options_20261113: sentiment Bullish. Call dollar vol 719,082.00 (78.0%), Put 202,725.00 (22.0%), total 921,807.00. Calls 796 contracts vs 338 puts.

Call Volume: 719,082.00 (78.0%) Put Volume: 202,725.00 (22.0%) Total: 921,807.00

Pure directional conviction (delta 40-60 filter, 2.6% of chain) shows strong call lean. Near-term expectations: upward bias to ~150+ strikes (Dec 18 call 150 bid 3.50). No divergence from technicals (both mildly bullish).

Note: Options flow shows heavy call buying at delta-constrained strikes, supporting bullish near-term read.

Key Statistics: MRK

$146.37 -0.62%
52-Week Range
$90.90 - $156.92
Market Cap
$360.84B
P/E (TTM)
148.00
PEG Ratio
N/A
Beta
-0.05
Next Earnings
N/A
Avg Volume
$6.45M
Dividend Yield
0.02%

Fundamental Snapshot

Valuation

P/E (trailing)148.00
EPS (trailing 12 mo)$0.99
Market cap$360.84B
Shares outstanding2,465.2M

Dividend

Dividend yield2.31%
Annual dividend$3.40
Ex-dividend date2026-09-15

Risk & range

Beta-0.05
52-week low$90.90
52-week high$156.92
Historical volatility32.4%

Ownership & trading

Institutional ownership54.3%
Average daily volume9.9M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below.

  • Merck (MRK) recently advanced its oncology pipeline with positive Phase 3 readouts for an investigational KEYTRUDA combination, reinforcing long-term growth narrative.
  • Analysts noted pending FDA decisions on MRK's HPV vaccine expansion indications, a potential near-term catalyst.
  • MRK declared its routine quarterly dividend (ex-dividend Sept 15, 2026 per fundamentals),็ปดๆŒ shareholder yield appeal amid pharma sector rotation.
  • Broader macro: defensive pharma flows increased as rates stabilized; MRK's negative beta (-0.05) suggests low correlation to broader equity swings.
  • No explicit earnings date in provided data, but historical Dec fiscal year-end (2025-12-01) implies upcoming annual reporting season as a watch item.

Context: These headlines support a stable fundamental backdrop that aligns with the bullish options sentiment observed in the embedded data, though technicals show compression near mid-range.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS JSON:

  • Trailing P/E is 148.00 with trailing EPS of 0.99; valuation appears elevated versus typical pharma peers, though no PEG (null) or forward PE (null) provided for relative comparison.
  • Dividend yield 2.31% with rate 3.40; ex-dividend 2026-09-15. Provides income context.
  • Market cap 360.84B, shares outstanding 2.46B, institutional ownership 54.31%.
  • Beta -0.05 (negative, defensively skewed). 52-week high 156.92, low 90.90.
  • Historical volatility 32.41%; average volume 9.88M.
  • Missing from data: revenue growth, margins (gross/operating/net), ROE, debt/equity, FCF, analyst target (all null). Cannot assess profitability trends or leverage.
  • Fundamentals show high multiple but defensive beta; technicals (price 147.29, SMA aligned) and sentiment (bullish options) diverge from rich P/E by suggesting near-term upward positioning rather than value.

Current Market Position

Current price per indicators: 147.29 (as of 2026-11-12 close). Minute bars show 2026-11-12 open 148.61, low 146.98, close ~147.29; 2026-11-13 11:10 bar close 146.52, intraday drifting lower from 148.61 to 146.52.

Recent daily: 30-day range high 154.02 (2026-10-22), low 138.80 (2026-10-05). Price sits mid-range.

Support (daily low cluster)
146.98
Resistance (recent high)
149.31
Bollinger Lower
140.77
Bollinger Upper
152.02

Intraday momentum: minute bars 11-13 show lower highs (146.66 to 146.52), volume thinning (~38K-61K), slight bearish intraday bias vs prior day.

Technical Analysis

Technical Indicators

Current Price
147.29
SMA 5
147.42
SMA 20
146.40
SMA 50
146.25
RSI 14
53.26
MACD
0.49
Signal
0.39
Hist
0.10
BB Upper
152.02
BB Lower
140.77
ATR 14
4.49

SMA alignment: 5 > 20 > 50 (147.42 > 146.40 > 146.25), mild bullish stacking, no bear cross. Price above all SMAs.

RSI 53.26 = neutral-positive momentum, no overbought. MACD positive histogram 0.10 = slight bullish bias. Bollinger mid 146.40, price just above; no squeeze (band width 11.25). 30-day range: price 147.29 is 56% up from low (138.80) to high (154.02).

True Sentiment Analysis (Delta 40-60 Options)

From MRK_options_20261113: sentiment Bullish. Call dollar vol 719,082.00 (78.0%), Put 202,725.00 (22.0%), total 921,807.00. Calls 796 contracts vs 338 puts.

Call Volume: 719,082.00 (78.0%) Put Volume: 202,725.00 (22.0%) Total: 921,807.00

Pure directional conviction (delta 40-60 filter, 2.6% of chain) shows strong call lean. Near-term expectations: upward bias to ~150+ strikes (Dec 18 call 150 bid 3.50). No divergence from technicals (both mildly bullish).

Note: Options flow shows heavy call buying at delta-constrained strikes, supporting bullish near-term read.

Key Price Levels (Observational Only)

Support (SMA50)
146.25
Support (BB Lower)
140.77
Resistance (BB Upper)
152.02
Resistance (30d High)
154.02

Interactive charts load with JavaScript. This text is the crawlable summary.